YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia
- University of Pennsylvania, United States
- Aurora St. Luke's Medical Center, United States
Abstract
Persistent human papillomavirus (HPV) infection of stratified squamous epithelial cells causes nearly five percent of cancer cases worldwide. HPV-positive oropharyngeal cancers harbor few mutations in the Hippo signaling pathway compared to HPV-negative cancers at the same anatomical site, prompting the hypothesis that an HPV-encoded protein inactivates the Hippo pathway and activates the Hippo effector YAP1. The HPV E7 oncoprotein is required for HPV infection and for HPV-mediated oncogenic transformation. We investigated the effects of HPV oncoproteins on YAP1 and found that E7 activates YAP1, promoting YAP1 nuclear localization in basal epithelial cells. YAP1 activation by HPV E7 required that E7 bind and degrade the tumor suppressor PTPN14. E7 required YAP1 transcriptional activity to extend the lifespan of primary keratinocytes, indicating that YAP1 activation contributes to E7 carcinogenic activity. Maintaining infection in basal cells is critical for HPV persistence, and here we demonstrate that YAP1 activation causes HPV E7 expressing cells to be retained in the basal compartment of stratified epithelia. We propose that YAP1 activation resulting from PTPN14 inactivation is an essential, targetable activity of the HPV E7 oncoprotein relevant to HPV infection and carcinogenesis.
Data availability
Original, uncropped Western blot images are contained in Figure 4B - Source Data 1, Figure 4 supplement 1 - Source Data 1, Figure 7 supplement 1D - Source Data 1, Figure 7 supplement 1F - Source Data 1
-
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalhttps://www.cbioportal.org/.
-
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockoutNCBI Gene Expression Omnibus, GSE121906.
-
Analysis of gene expression in primary human foreskin keratinocytes (HFK) +/- HPV18 E7NCBI Gene Expression Omnibus, GSE150201.
-
Human neonatal foreskin epidermisNCBI Gene Expression Omnibus, GSE147482.
Article and author information
Author details
Joshua Hatterschide
Funding
National Institute of Allergy and Infectious Diseases (T32 AI007324)
- Joshua Hatterschide
National Institute of Dental and Craniofacial Research (F31 DE030365)
- Joshua Hatterschide
American Cancer Society (131661-RSG-18-048-01-MPC)
- Joshua Hatterschide
- Paola Castagnino
- Hee Won Kim
- Elizabeth A White
National Institute of Allergy and Infectious Diseases (R01 AI148431)
- Joshua Hatterschide
- Paola Castagnino
- Hee Won Kim
- Elizabeth A White
National Institute of Dental and Craniofacial Research (R01 DE027185)
- Devraj Basu
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30 AR068589)
- Elizabeth A White
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The University of Pennsylvania Skin Biology and Diseases Resource-based Center (SBDRC) was supported by NIH grant P30 AR068589
Ethics
Human subjects: All patient-derived materials and clinical data in this study were obtained from patients who underwent surgery to remove an oral cavity or oropharyngeal cancer. Patients were counseled preoperatively and provided informed consent under University of Pennsylvania IRB-approved protocol #417200 "Head and Neck Cancer Specimen Bank" (PI: D. Basu) by signing a combined informed consent and HIPAA form for use of tissue for research. Consent under this longstanding and currently active protocol explicitly provides permission to access surgically removed fresh tumor tissue that is not needed for pathologic analysis as well as to access FFPE tumor tissue in the pathology archive at a later date. It also provides explicit permission to publish deidentified analyses of these resources. Patient care is not altered under this protocol, which carries minimal risk. Minors and other vulnerable populations are not included in the study.
Reviewing Editor
- Melanie M Brinkmann, Technische Universität Braunschweig, Germany
Publication history
- Preprint posted: November 10, 2021 (view preprint)
- Received: November 11, 2021
- Accepted: February 15, 2022
- Accepted Manuscript published: February 16, 2022 (version 1)
- Version of Record published: March 28, 2022 (version 2)
Copyright
© 2022, Hatterschide et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,866
- Page views
-
- 361
- Downloads
-
- 13
- Citations
Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
YAP1 activation by human papillomavirus E7 promotes basal cell identity in squamous epithelia
eLife 11:e75466.
https://doi.org/10.7554/eLife.75466
Further reading
-
- Cancer Biology
- Cell Biology
Pancreatic ductal adenocarcinoma (PDAC) continues to show no improvement in survival rates. One aspect of PDAC is elevated ATP levels, pointing to the purinergic axis as a potential attractive therapeutic target. Mediated in part by highly druggable extracellular proteins, this axis plays essential roles in fibrosis, inflammation response and immune function. Analysing the main members of the PDAC extracellular purinome using publicly available databases discerned which members may impact patient survival. P2RY2 presents as the purinergic gene with the strongest association with hypoxia, the highest cancer cell-specific expression and the strongest impact on overall survival. Invasion assays using a 3D spheroid model revealed P2Y2 to be critical in facilitating invasion driven by extracellular ATP. Using genetic modification and pharmacological strategies we demonstrate mechanistically that this ATP-driven invasion requires direct protein-protein interactions between P2Y2 and αV integrins. DNA-PAINT super-resolution fluorescence microscopy reveals that P2Y2 regulates the amount and distribution of integrin αV in the plasma membrane. Moreover, receptor-integrin interactions were required for effective downstream signalling, leading to cancer cell invasion. This work elucidates a novel GPCR-integrin interaction in cancer invasion, highlighting its potential for therapeutic targeting.
-
- Cancer Biology
Osteosarcoma (OS) is the common primary bone cancer that affects mostly children and young adults. To augment the standard-of-care chemotherapy, we examined the possibility of protein-based therapy using mesenchymal stem cells (MSCs)-derived proteomes and OS-elevated proteins. While a conditioned medium (CM), collected from MSCs, did not present tumor-suppressing ability, the activation of PKA converted MSCs into induced tumor-suppressing cells (iTSCs). In a mouse model, the direct and hydrogel-assisted administration of CM inhibited tumor-induced bone destruction, and its effect was additive with cisplatin. CM was enriched with proteins such as calreticulin, which acted as an extracellular tumor suppressor by interacting with CD47. Notably, the level of CALR transcripts was elevated in OS tissues, together with other tumor-suppressing proteins, including histone H4, and PCOLCE. PCOLCE acted as an extracellular tumor-suppressing protein by interacting with amyloid precursor protein, a prognostic OS marker with poor survival. The results supported the possibility of employing a paradoxical strategy of utilizing OS transcriptomes for the treatment of OS.
